Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.79 (
granzyme B
)
3,301
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Granzyme B
plays an essential role in cytotoxic T lymphocyte (CTL)-mediated cell killing. Recent studies suggest that
granzyme B
may exert its effect by cleaving and activating CPP32, a member of the interleukin-1 beta-converting enzyme/Ced-3 family of cysteine proteases. We have examined the processing and activation of
CMH-1
, a close homologue of CPP32, by
granzyme B
in vitro. We have found that
granzyme B
specifically cleaves
CMH-1
at Asp198-Ser199 between the p20 and p12 and activates the cysteine protease. Cleavage between p20 and the prosequence of
CMH-1
at Asp23-Ala24 is autocatalytic and is not required for
CMH-1
activity in vitro. The cleavage and activation of
CMH-1
by
granzyme B
in vitro sugge st that, in addition to CPP32,
CMH-1
may also play a role in CTL-mediated cell killing.
...
PMID:Processing and activation of CMH-1 by granzyme B. 863 95
Members of the ICE/Ced-3 gene family are likely effector components of the cell death machinery. Here, we characterize a novel member of this family designated ICE-LAP6. By phylogenetic analysis, ICE-LAP6 is classified into the Ced-3 subfamily which includes Ced-3, Yama/CPP32/apopain, Mch2, and
ICE-LAP3
/Mch3/
CMH-1
. Interestingly, ICE-LAP6 contains an active site QACGG pentapeptide, rather than the QACRG pentapeptide shared by other family members. Overexpression of ICE-LAP6 induces apoptosis in MCF7 breast carcinoma cells. More importantly, ICE-LAP6 is proteolytically processed into an active cysteine protease by
granzyme B
, an important component of cytotoxic T cell-mediated apoptosis. Once activated, ICE-LAP6 is able to cleave the death substrate poly(ADP-ribose) polymerase into signature apoptotic fragments.
...
PMID:ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. 866 94
Cytotoxic T lymphocytes (CTLs) and natural killers (NK) cells provide immune surveillance against viruses and neoplasms, and play a central role in the pathogenesis of autoimmune disease, AIDS and graft rejection. Thus, it is important to understand the precise molecular mechanism(s) whereby cytotoxic lymphocytes destroy susceptible target cells. Granule-mediated cytotoxicity requires a combination of both perforin and
granzyme B
. Perforin polymerizes to form transmembrane channels and presumably allows
granzyme B
access to target cell substrates, which until recently, were unknown. One clue to the identity of the physiological substrate(s) activated by
granzyme B
comes from its unusual specificity for cleaving synthetic substrates after aspartate residues. Members of the ICE/CED-3 family of cysteine proteases are prime candidates as they are important apoptotic effectors and are expressed as zymogens, which can be processed to form active heterodimeric enzymes after cleavage at specific aspartate residues. Previous studies have shown that
granzyme B
proteolytically activates the cell death effector Yama/CPP32/apopain (referred to here as Yama). Here we report that
granzyme B
also activates
ICE-LAP3
/Mch3/
CMH-1
(referred to here as
ICE-LAP3
), which, along with Yama and Mch2, forms a subset of the ICE/CED-3 family of cysteine proteases most closely related to the Caenorhabditis elegans cell death gene, CED-3. Importantly, Jurkat T cells incubated with
granzyme B
and a sublytic concentration of perforin undergo apoptosis, which is preceded by the activation of endogenous
ICE-LAP3
. Thus, we propose that
granzyme B
mediates apoptosis by directly engaging the target cell's death effector machinery, which is probably composed of an arsenal of intracellular, CED-3-like cysteine proteases.
...
PMID:Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3. 880 7
Lymphocyte granule-mediated apoptosis is postulated to entail the formation of membrane pores by perforin. Then soluble granzyme reaches the cytosol either through these pores or by reparative pinocytosis. We demonstrate here that Jurkat cells bind and internalize
granzyme B
via high affinity binding sites without toxic consequence. Apoptosis occurs, however, if sublytic perforin is added to targets washed free of soluble
granzyme B
. We suggest that granule-mediated apoptosis mimics viral strategies for cellular entry. Accordingly, co-internalization of
granzyme B
with adenovirus, a virus that escapes endosomes to reach the cytosol, also induced apoptosis. Poly(ADP-ribose) polymerase cleavage and processing of CPP32,
ICE-LAP3
, and Mch2 were detected at 30 min, while cytosolic acidification and DNA fragmentation occurred at 60 min. Annexin V binding and membrane permeabilization arose at 4 h. The concurrent activation of the Ced-3 proteases differed from the rate at which each cysteine protease is cleaved in vitro by
granzyme B
. Thus,
granzyme B
may not directly process these proteases in whole cells but rather may function by activating a more proximal enzyme. These results indicate that adenovirus-mediated delivery of
granzyme B
is suitable for elucidating biochemical events that accompany granule-mediated apoptosis.
...
PMID:New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. 891 May 61